Use of Erbium Laser for Extraction of the Third Molars
Third Molar Extraction, Impacted Third Molar Tooth
About this trial
This is an interventional treatment trial for Third Molar Extraction focused on measuring Impacted third molars, Erbium laser, Atraumatic extraction
Eligibility Criteria
Inclusion Criteria:
- Signing of written informed consent of the patient to participate in a study
- Age from 25 to 50 years old
- Indications for impacted third molar extraction
- Patients who are medically stable
- Therapeutic and surgical oral hygiene before surgery (absence of inflammatory diseases, caries, pulpitis, periodontitis in oral cavity)
Exclusion Criteria:
- Refusal of the patient from further participation in the study
- Pregnancy diagnosed after the inclusion into the trial
- Non-compliance by the patient with postoperative recommendations
- Absence of a lower second molar
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group with impacted third molar, extracted by cutting and rotary tools
Group with impacted third molar, extracted by erbium laser 2.94 nm
The study group will include 28 patients with indications (impacted third molars that exerts pressure on the adjacent tooth and cause inflammation process in the surrounding tissue; absence of antagonist; pericorinitis; periodontitis; periodontal pockets) for the impacted third molar extraction. Patients will be comparable by gender and age, the patients age will be between 18 and 70 years. Patients should be with therapeutic and surgical oral hygiene and without co-morbidities.
The study group will include 28 patients with indications (impacted third molars that exerts pressure on the adjacent tooth and cause inflammation process in the surrounding tissue; absence of antagonist; pericorinitis; periodontitis; periodontal pockets) for the impacted third molar extraction.Patients will be comparable by gender and age, the patients age will be between 18 and 70 years. Patients should be with therapeutic and surgical oral hygiene and without co-morbidities.